Medlife dispatches at-home COVID-19 testing in select urban areas Kumar Jeetendra | April 29, 2020 E-Health stage Medlife on Tuesday said it has banded together with authorize labs to dispatch at-home testings for COVID-19 in select urban communities and plans to grow it going ahead. The cost of a test is set at Rs 4,500 and will be directed by labs approved by the Indian Council of Medical Research (ICMR), …
Hydroxychloroquine to be given to Health workers treating COVID-19 patients Kumar Jeetendra | April 29, 2020 Healthcare workers associated with the treatment of coronavirus patients will be given hydroxychloroquine (HCQ) tablets as a preventive prescription, the Maharashtra government has said and given rules on the utilization of the medication. State Health secretary Pradeep Vyas in an ongoing round said the medication will be given to specialists, attendants and clinical staff engaged …
Bharat Biotech, Thomas Jefferson University ties up to create antibody for Covid-19 Kumar Jeetendra | May 21, 2020 Antibody producer Bharat Biotech and Thomas Jefferson University of Philadelphia have marked a restrictive deal to build up another immunization contender for Covid-19. The epic immunization was created utilizing a current deactivated rabies antibody as a vehicle for coronavirus proteins. This immunization is known to create a solid invulnerable reaction and is affirmed for the …
CanSino Biologics Inc New Corona immunization seems protected, compelling in early trials Kumar Jeetendra | May 24, 2020 A coronavirus immunization developed by CanSino Biologics Inc gives off an impression of being sheltered and prompted a quick invulnerable reaction in its first human trial, Chinese analysts gave an account of Friday in The Lancet clinical diary. CanSino utilizes a debilitated regular cold infection called an adenovirus – and Friday’s investigation indicated individuals whose …
Covid may never leave even with an antibody : Report Kumar Jeetendra | May 28, 2020 Considerably after a COVID-19 antibody is created and conveyed, the coronavirus will probably stay for quite a long time to come, and may in the long run, become endemic like HIV, measles and chickenpox, The Washington Post detailed. As per the US every day, specialists in the study of disease transmission state grasping the delayed …
COVID-19 patients with extreme pneumonia ought to be considered for moving to ICU: Protocol Kumar Jeetendra | June 7, 2020 Suggestive COVID-19 patients who have “extreme pneumonia” with a respiratory pace of 30 breath for every moment ought to be considered for moving to ICU, as indicated by a clinical administration convention for grown-up patients experiencing the malady. A COVID-19 patient with cut off pneumonia likewise has an oxygen immersion level (Spo2) of under 90 …
Researchers close ‘discovery’ on antibody treatment Kumar Jeetendra | June 7, 2020 In the midst of the coronavirus pandemic, which has contaminated in excess of 69 lakh individuals and slaughtered more than four lakh over the world, researchers might be near a discovery on a neutralizer treatment that can spare the lives of individuals tainted with the lethal infection, The Guardian has revealed. The researchers have built …
Destitution flood to more than 1 billion due to coronavirus, cautions study Kumar Jeetendra | June 12, 2020 Worldwide destitution is set to transcend 1 billion individuals by and by because of the coronavirus pandemic, which is diminishing the salary of the world’s least fortunate by USD 500 million every day, as indicated by new examination distributed Friday. The exploration by King’s College London and the Australian National University focuses to neediness expanding …
“TOTAL ANTIBODY DETECTION ASSAY KIT” for COVID -19 launched in India by J.Mitra Kumar Jeetendra | June 17, 2020 New Delhi, 17th June 2020: J Mitra & Co. Pvt Ltd, India’s leading global MNC in the In-Vitro Diagnostics (IVD) industry has launched its state-of-the-art Covid-19 Test Kit in the Indian market. Based on the Double Sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] MICROLISA. It is a serology-based total …
Coronavirus (COVID-19) Sample Tracking Packages Kumar Jeetendra | June 25, 2020 To assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy for dealing with the SARS-CoV-2 virus pandemic – Ziath has introduced two optimized packages for reliable tracking of patient samples submitted for Coronavirus (COVID-19) testing. For large-scale, high-density Coronavirus (COVID-19) testing labs – Ziath has introduced an attractively …
Specialists express worldwide push to create COVID-19 immunization require enormous financial plan Kumar Jeetendra | June 27, 2020 Specialists behind a worldwide push to create and reveal an antibody and other treatment for the coronavirus state their aspirations require a major financial plan. The World Health Organization and its partners made a pitch for their ACT-Accelerator that plans to get a COVID-19 immunization and treatment instruments to the neediest individuals around the globe, …
ICMR affirms Covaxin dispatch likely by August 15, clinical preliminaries optimized Kumar Jeetendra | July 3, 2020 An ICMR representative has affirmed the credibility of a letter by ICMR Head that said the antibody preliminaries for Hyderabad-based Bharat Biotech’s COVID-19 immunization Covaxin have been optimized and that it could be propelled most recent by August 15. ICMR had on July 2 purportedly asked Bharat Biotech in an inner correspondence to quick track …
